With approval to study the transcatheter replacement device in patients with severe tricuspid regurgitation, VDyne is ...
Vdyne is set to launch a pivotal trial for its transcatheter tricuspid valve replacement system, aiming to address severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results